Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-24-132464
Filing Date
2024-12-30
Accepted
2024-12-30 15:32:48
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 12936
  Complete submission text file 0001104659-24-132464.txt   14688
Mailing Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 489-9000
RAPT Therapeutics, Inc. (Subject) CIK: 0001673772 (see all company filings)

EIN.: 473313701 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-91191 | Film No.: 241589481
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 900 LARKSPUR LANDING CIRCLE, SUITE 150 LARKSPUR CA 94939
Business Address 900 LARKSPUR LANDING CIRCLE, SUITE 150 LARKSPUR CA 94939 415-877-4887
Foresite Capital Fund VI LP (Filed by) CIK: 0001932516 (see all company filings)

EIN.: 881506258 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G